Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT05965908

Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome

Conditions: Polycystic Ovary

Sex: Female

Ages: 18 Years – 45 Years

Healthy volunteers: No

Phase: PHASE3

Enrollment: 183

Sponsor: Beni-Suef University

Location: Beni-suef university Hospital Banī Suwayf Beni Suweif Governorate

Summary

The aim of this study is to compare the hormonal, metabolic and clinical effects of metformin and liraglutide in infertile women with PCOs.

Eligibility Criteria

Inclusion Criteria: * women aged 18-45 years * Poly cystic ovary syndrome based on the Rotterdam criteria Exclusion Criteria: 1. congenital adrenal hyperplasia, 2. poorly controlled thyroid disease 3. Taking antidiabetic drugs which can affect insulin resistance 4. chronic kidney disease 5. liver dysfunction (AST or ALT 6. Documented use of oral hormonal contraceptives and hormone-releasing implants 7. intolerance or allergy to liraglutide or metformin

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05965908). StuddyBuddy aggregates publicly available trial information.